Most Read Articles
4 days ago
The appropriate cutoff value in predicting combined cardiovascular outcomes in patients with type 2 diabetes (T2D) is 125 mm Hg for home morning systolic blood pressure (MSBP), suggests a new study.
Pearl Toh, 3 days ago
Whether the 2017 ACC/AHA* blood pressure (BP) guidelines should be adopted in Asian countries was the topic of a much-anticipated discussion here at the Asian Pacific Society of Cardiology (APSC) Congress 2018 in Taiwan last week.
Jairia Dela Cruz, 5 days ago
Rheumatoid arthritis patients who use low-dose aspirin in primary prevention of cardiovascular (CV) disease have similar risks of major toxicity and CV events as those who are not exposed to aspirin, according to a secondary analysis of the PRECISION* trial.
15 May 2018

A study by researchers at Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) found that, even at levels currently considered normal, low-density lipoprotein cholesterol (LDL-C) is a prime predictor of the presence of atherosclerotic plaques in arteries. [J Am Coll Cardiol 2017;70:2979–2991]

Presence of rheumatoid factor tied to 10-year cardiovascular disease in RA patients

07 Sep 2017

The presence of rheumatoid factor (RF) rather than anticyclic citrullinated peptide antibodies (anti-CCP) may predict 10-year cardiovascular disease (CVD) in patients with rheumatoid arthritis (RA), a recent study has found.

Researchers sought to determine whether anti-CCP and RF were risk factors for 10-year CVD in RA patients by analysing data from the Nijmegen early RA inception cohort, in which those with newly diagnosed RA (n=929), consecutively included since 1985, were followed up regularly. Anti-CCP and RF were determined at baseline during diagnosis.

The first CVD event (ischaemic heart disease, nonhaemorrhagic cerebrovascular accident [CVA] or peripheral artery disease [PAD]) after baseline as retrieved from physician diagnosis was the primary outcome. Researchers checked fatality against death certificates. They performed Cox regression plus correction for baseline confounders to estimate the effect of anti-CCP, RF and their interaction on 10-year CVD-free survival.

Of the included patients, 628 were anti-CCP‒positive and 697 were RF-positive. There were a total of 162 CV events (101 ischaemic heart disease, 45 CVA and 16 PAD), of which 15 were fatal, during a median follow-up of 7.5 years.

The adjusted hazard ratio (aHR) was 1.17 (95 percent CI, 0.82 to 1.67) for anti-CCP and 1.52 (1.00 to 2.30) for RF. There was an even greater association between RF positivity and CVD among anti-CCP‒negative patients (aHR, 2.09; 1.18 to 3.71). No significant interaction was seen between anti-CCP and RF (p=0.098).

In an earlier study involving postmenopausal women, CVD risk strongly correlated with CVD risk factors, joint pain severity and inflammation, but not with anti-CCP positivity or RF positivity. [Arthritis Rheumatol 2015;67:2311-22]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
The appropriate cutoff value in predicting combined cardiovascular outcomes in patients with type 2 diabetes (T2D) is 125 mm Hg for home morning systolic blood pressure (MSBP), suggests a new study.
Pearl Toh, 3 days ago
Whether the 2017 ACC/AHA* blood pressure (BP) guidelines should be adopted in Asian countries was the topic of a much-anticipated discussion here at the Asian Pacific Society of Cardiology (APSC) Congress 2018 in Taiwan last week.
Jairia Dela Cruz, 5 days ago
Rheumatoid arthritis patients who use low-dose aspirin in primary prevention of cardiovascular (CV) disease have similar risks of major toxicity and CV events as those who are not exposed to aspirin, according to a secondary analysis of the PRECISION* trial.
15 May 2018

A study by researchers at Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) found that, even at levels currently considered normal, low-density lipoprotein cholesterol (LDL-C) is a prime predictor of the presence of atherosclerotic plaques in arteries. [J Am Coll Cardiol 2017;70:2979–2991]